You may also like
Terumo Americas Holding, Inc. Aquires Harvest Technologies
Terumo Americas Holding, Inc., a U.S. subsidiary of Japan’s Terumo Corporation, one of the world’s leading medical device manufacturers with $3.4 billion in sales and operations in more than 160 nations, today announced that it has entered into a Stock Purchase Agreement to acquire all outstanding shares of Harvest Technologies Corporation, an innovative biotechnology company working to commercialize the world’s first point-of-care technology that allows physicians to derive highly concentrated autologous, adult stem cells from their patients in just 15 minutes.
Balloon Aortic Valvuloplasty (BAV) as a Bridge to Aortic Valve Replacement in Cancer Patients Who Require Urgent Non-Cardiac Surgery
Balloon aortic valvuloplasty (BAV) is a percutaneous treatment option for severe, symptomatic aortic stenosis. Due to early restenosis and failure to improve long term survival, BAV is considered a palliative measure in patients who are not suitable for open heart surgerydue to increased perioperative risk.
Quality, Patient Safety, and the Cardiac Surgical Team
This article reviews a decade of discussion surrounding quality and safety issues in cardiac surgery